Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOFFEE: Cardiotoxicity of Capecitabine vs Teysuno
NCT01845337Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Feb 2014
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in esophageal cancer, gastric cancer (GC), gastroesophageal junction cancer, small bowel cancer, colorectal cancer (CRC), sponsored by University of Edinburgh. Started Feb 2014; status: completed.
02
Drugs
tegafur
03
Conditions
esophageal cancergastric cancer (GC)gastroesophageal junction cancersmall bowel cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01845337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845337.